No doubt they may well accumulate, ramp, downramp, etc. And no doubt they are nice to their dogs and take them for a walk now and again. At times they may make pleasant conversation in chat.
But are they always transparent? Is what they do always good for the market? Let alone MSB?
Are they fair about engaging in the implications of the ann for MSB clinical program update for MPC-150-IM in Heart failure?
Do they set the hares running on side issues, making spurious claims, and then disputing them? Acting as a distraction from the main topic?
Those are the relevant questions to ask. IMO.
MSB Price at posting:
$1.49 Sentiment: Buy Disclosure: Held